scholarly journals Low density lipoprotein modified silica nanoparticles loaded with docetaxel and thalidomide for effective chemotherapy of liver cancer

Author(s):  
Man Ao ◽  
Xu Xiao ◽  
Yazhou Ao
Nanomedicine ◽  
2014 ◽  
Vol 9 (14) ◽  
pp. 2123-2141 ◽  
Author(s):  
Lacy Reynolds ◽  
Rohit S Mulik ◽  
Xiaodong Wen ◽  
Archana Dilip ◽  
Ian R Corbin

Author(s):  
Dean A. Handley ◽  
Cynthia M. Arbeeny ◽  
Larry D. Witte

Low density lipoproteins (LDL) are the major cholesterol carrying particles in the blood. Using cultured cells, it has been shown that LDL particles interact with specific surface receptors and are internalized via a coated pit-coated vesicle pathway for lysosomal catabolism. This (Pathway has been visualized using LDL labeled to ferritin or colloidal gold. It is now recognized that certain lysomotropic agents, such as chloroquine, inhibit lysosomal enzymes that degrade protein and cholesterol esters. By interrupting cholesterol ester hydrolysis, chloroquine treatment results in lysosomal accumulation of cholesterol esters from internalized LDL. Using LDL conjugated to colloidal gold, we have examined the ultrastructural effects of chloroquine on lipoprotein uptake by normal cultured fibroblasts.


Sign in / Sign up

Export Citation Format

Share Document